ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Nephrocare delivered robust 23.7% revenue growth driven by international expansion and volume gains. While margins improved via operating leverage, high working capital cycles and binary outcomes in tender markets like Saudi Arabia remain key risks.
Nephrocare Health Services (NephroPlus) reported Q1FY27 revenue of ₹281.8 Cr, up 23.7% YoY. Strategy focuses on international scaling and high-margin organized dialysis network leadership.
Nephrocare reports strong FY26 performance with 32% revenue growth and significant margin expansion, driven by international expansion and platform-led operational efficiencies.
Nephrocare Health Services (NephroPlus) reported strong FY26 performance with revenue reaching ₹998.8 Cr, driven by international expansion and increased treatment volumes.